
Page#1
BRUNSWICK CORPORATION
Consolidated Statements of Operations
For the Years Ended December 31
(in millions, except per share data) 2017 2016 2015
Net sales $ 4,510.0 $ 4,153.9 $ 3,780.2
Cost of sales 3,275.3 2,973.6 2,720.2
Selling, general and administrative expense 608.1 572.1 527.8
Research and development expense 138.5 131.0 113.9
Pension settlement charge 96.6 55.1 82.3
Restructuring, exit, integration and impairment charges 36.6 15.2 4.7
Operating earnings 354.9 406.9 331.3
Equity earnings 6.1 4.3 3.7
Other income, net 6.1 3.2 5.3
Earnings before interest and income taxes 367.1 414.4 340.3
Interest expense (26.4) (27.2) (27.7)
Interest income 2.6 1.8 2.2
Earnings before income taxes 343.3 389.0 314.8
Income tax provision 156.0 116.4 83.9
Net earnings from continuing operations 187.3 272.6 230.9
Discontinued operations:
Earnings (loss) from discontinued operations, net of tax (40.9) 3.4 (2.3)
Gain on disposal of discontinued operations, net of tax — — 12.8
  Net earnings (loss) from discontinued operations, net of tax (40.9) 3.4 10.5
Net earnings $ 146.4 $ 276.0 $ 241.4
Earnings (loss) per common share:
Basic
Earnings from continuing operations $ 2.10 $ 2.99 $ 2.49
Earnings (loss) from discontinued operations (0.46) 0.04 0.11
Net earnings $ 1.64 $ 3.03 $ 2.60
Diluted
Earnings from continuing operations $ 2.08 $ 2.96 $ 2.45
Earnings (loss) from discontinued operations (0.46) 0.04 0.11
Net earnings $ 1.62 $ 3.00 $ 2.56
Weighted average shares used for computation of:
Basic earnings per common share 89.4 91.2 93.0
Diluted earnings per common share 90.1 92.0 94.3
Cash dividends declared per common share $ 0.685 $ 0.615 $ 0.525
The Notes to Consolidated Financial Statements are an integral part of these consolidated statements.
49
Page#2
BRUNSWICK CORPORATION
Consolidated Balance Sheets
As of December 31
2017 2016
(in millions)
Assets
Current assets
Cash and cash equivalents, at cost, which approximates fair value $ 448.8 $ 422.4
Restricted cash 9.4 11.2
Short-term investments in marketable securities 0.8 35.8
Total cash and short-term investments in marketable securities 459.0 469.4
Accounts and notes receivable, less allowances of $9.1 and $12.7 480.2 411.5
Inventories
Finished goods 506.9 488.8
Work-in-process 96.8 68.3
Raw materials 161.9 141.9
Net inventories 765.6 699.0
Prepaid expenses and other 73.1 37.1
Current assets held for sale 68.8 71.5
Current assets 1,846.7 1,688.5
Property
Land 19.9 17.9
Buildings and improvements 340.6 307.7
Equipment 991.9 923.8
Total land, buildings and improvements and equipment 1,352.4 1,249.4
Accumulated depreciation (812.5) (777.1)
Net land, buildings and improvements and equipment 539.9 472.3
Unamortized product tooling costs 119.6 96.7
Net property 659.5 569.0
Other assets
Goodwill 425.3 413.8
Other intangibles, net 144.4 160.1
Equity investments 25.0 20.7
Deferred income tax asset 165.6 307.8
Other long-term assets 45.1 43.4
Long-term assets held for sale 46.6 81.4
Other assets 852.0 1,027.2
Total assets $ 3,358.2 $ 3,284.7
51
Page#3
BRUNSWICK CORPORATION
Consolidated Balance Sheets
As of December 31
2017 2016
(in millions)
Liabilities and shareholders’ equity
Current liabilities
Current maturities of long-term debt $ 5.6 $ 5.6
Accounts payable 409.7 378.2
Accrued expenses 563.6 521.3
Current liabilities held for sale 56.2 59.8
Current liabilities 1,035.1 964.9
Long-term liabilities
Debt 431.8 433.8
Postretirement benefits 220.8 276.3
Other 184.9 162.9
Long-term liabilities held for sale 2.7 6.7
Long-term liabilities 840.2 879.7
Shareholders’ equity
Common stock; authorized: 200,000,000 shares, $0.75 par value; issued: 102,538,000 shares;
outstanding: 87,537,000 and 89,317,000 shares 76.9 76.9
Additional paid-in capital 374.4 382.0
Retained earnings 1,966.8 1,881.0
Treasury stock, at cost: 15,001,000 and 13,221,000 shares (575.4) (465.2)
Accumulated other comprehensive loss, net of tax:
 Foreign currency translation (31.6) (51.9)
 Defined benefit plans:
 Prior service credits (5.6) (5.1)
 Net actuarial losses (310.8) (372.0)
 Unrealized losses on derivatives (11.8) (5.6)
Accumulated other comprehensive loss, net of tax (359.8) (434.6)
Shareholders’ equity 1,482.9 1,440.1
Total liabilities and shareholders’ equity $ 3,358.2 $ 3,284.7
The Notes to Consolidated Financial Statements are an integral part of these consolidated statements.
52
Page#4
BRUNSWICK CORPORATION
Consolidated Statements of Cash Flows
For the Years Ended December 31
(in millions) 2017 2016 2015
Cash flows from operating activities
Net earnings $ 146.4 $ 276.0 $ 241.4
Less: earnings (loss) from discontinued operations, net of tax (40.9) 3.4 10.5
Net earnings from continuing operations 187.3 272.6 230.9
Depreciation and amortization 98.2 91.0 77.1
Stock compensation expense 17.8 16.1 20.8
Pension expense including settlement charges, net of (funding) 32.2 (4.8) 20.4
Asset impairment charges 18.7 2.4 4.7
Deferred income taxes 118.4 62.7 43.3
Changes in certain current assets and current liabilities
Change in accounts and notes receivable (58.1) (3.8) (11.4)
Change in inventory (65.6) (40.4) (9.6)
Change in prepaid expenses and other, excluding income taxes 3.5 (0.9) (3.1)
Change in accounts payable 34.7 34.8 5.3
Change in accrued expenses 47.0 (17.3) (31.9)
Long-term extended warranty contracts and other deferred revenue 17.1 10.3 4.0
Income taxes (35.9) 21.1 7.8
Other, net 1.9 (20.3) (18.1)
Net cash provided by operating activities of continuing operations 417.2 423.5 340.2
Net cash provided by (used for) operating activities of discontinued operations (16.9) 11.8 (9.7)
Net cash provided by operating activities 400.3 435.3 330.5
Cash flows from investing activities
Capital expenditures (189.3) (172.5) (114.1)
Purchases of marketable securities — (35.0) (47.6)
Sales or maturities of marketable securities 35.0 10.7 119.3
Investments (3.2) 5.1 0.9
Acquisition of businesses, net of cash acquired (15.5) (276.1) (29.7)
Proceeds from the sale of property, plant and equipment 8.3 1.9 2.4
Other, net (0.5) 1.3 —
Net cash used for investing activities of continuing operations (165.2) (464.6) (68.8)
Net cash provided by (used for) investing activities of discontinued operations (13.7) (21.4) 26.1
Net cash used for investing activities (178.9) (486.0) (42.7)
Cash flows from financing activities
Net proceeds from issuances of long-term debt — 1.0 0.1
Payments of long-term debt including current maturities (3.0) (2.8) (3.1)
Common stock repurchases (130.0) (120.3) (120.0)
Cash dividends paid (60.6) (55.4) (48.3)
Proceeds from share-based compensation activity 6.2 14.9 4.5
Tax withholding associated with shares issued for share-based compensation (14.8) (20.9) (8.7)
Other, net — (1.9) —
Net cash used for financing activities of continuing operations (202.2) (185.4) (175.5)
Net cash provided by (used for) financing activities of discontinued operations (1.5) (0.4) 5.0
Net cash used for financing activities (203.7) (185.8) (170.5)
Effect of exchange rate changes 6.9 0.1 (15.6)
Net increase (decrease) in Cash and cash equivalents and Restricted cash 24.6 (236.4) 101.7
Cash and cash equivalents and Restricted cash at beginning of period 433.6 670.0 568.3
Cash and cash equivalents and Restricted cash at end of period 458.2 433.6 670.0
 Less: Restricted cash 9.4 11.2 12.7
Cash and cash equivalents at end of period $ 448.8 $ 422.4 $ 657.3
Supplemental cash flow disclosures:
Interest paid $ 33.0 $ 30.1 $ 28.5
Income taxes paid, net $ 73.5 $ 32.6 $ 32.8
The Notes to Consolidated Financial Statements are an integral part of these consolidated statements.
53